Sponsor hub
Dartmouth-Hitchcock Medical Center clinical trial failures
Review 26 stopped clinical trials from Dartmouth-Hitchcock Medical Center, including disease areas, phases, and classified stop reasons.
This page groups real ClinicalTrials.gov-derived stopped trial records. The strongest added signal is the stop-reason classification: 2 of these records are likely biological failure signals, while the rest may reflect operational, strategic, regulatory, funding, enrollment, or unclear stop reasons.
Dominant stop reasons
- OPERATIONAL
- 19
- OTHER/UNKNOWN
- 5
- EFFICACY/FUTILITY
- 1
- SAFETY
- 1
Notable sponsors
- Dartmouth-Hitchcock Medical Center
- 26
Related phases
- Phase II
- 10
- Phase I
- 8
- Early Phase I
- 3
- Unknown
- 3
- Phase III
- 1
Crawlable stopped-trial records
Open ExploreShowing up to 26 representative records from this slice. Each link opens the trial detail page with source attribution and stop-reason context.
Early Phase I Pyoderma Gangrenosum trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Issues with funding and IND holder
Unknown Vascular Access Ports trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Study was not funded
Phase I Chronic Graft-versus-host-disease trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Insufficient accrual
Early Phase I Thoracic Neoplasm trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Enrollment was closed as efforts had become more challenging, and the lab indicated that they were able to obtain their primary objective with the number that had already been enrolled.
Phase II Rheumatoid Arthritis trial by Dartmouth-Hitchcock Medical Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Vasoplegia trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Lack of funding
Phase I Breast Cancer trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Low accrual
Phase I Carcinoma, Non-small-cell Lung trial by Dartmouth-Hitchcock Medical Center. Stop reason: OTHER/UNKNOWN.
other trials show no survival benefit of bexarotene with platinum-based chemo
Phase II Metastatic Melanoma trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Low accrual not allowing to support statistical endpoints
Phase II Neuropathy trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
The study has been suspended for slower than anticipated enrollment to date.
Phase II Diabetic Gastroparesis trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Lack of recruitment
Phase II Metastatic Breast Cancer trial by Dartmouth-Hitchcock Medical Center. Stop reason: OTHER/UNKNOWN.
Closed due to achievement of primary study endpoint
Phase I Leukemia trial by Dartmouth-Hitchcock Medical Center. Stop reason: SAFETY.
Medarex (supplier of BsAb) stopped study due to toxicities experienced at other sites on unrelated trials halting manufacturing of BsAb
Unknown Hematologic Malignancies trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Lack of enrollment.
Phase I Glioblastoma trial by Dartmouth-Hitchcock Medical Center. Stop reason: OTHER/UNKNOWN.
Investigator is leaving Dartmouth
Phase II Acute Gout trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Colaborator withdrew support.
Phase IV Schizophrenia trial by Dartmouth-Hitchcock Medical Center. Stop reason: OTHER/UNKNOWN.
No stop-reason text available in the compact dataset.
Phase II Pancreatitis trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
no funding was awarded
Phase I Neoplasms trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Sponsor withdrew support
Phase III Post-ERCP Acute Pancreatitis trial by Dartmouth-Hitchcock Medical Center. Stop reason: EFFICACY/FUTILITY.
Futility
Phase I Lung Cancer trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Study funding was dropped.
Unknown Caesarean Delivery trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
two other institutions that were in the center thought they weren't going to be able to recruit enough patients
Phase II Metastatic Renal Cell Carcinoma trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
low accrual not allowing site to meeting statistical endpoints
Phase I Advanced Solid Tumors trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Administrative suspension. PI/grant holder transferred to new institution.
Early Phase I Chronic Lymphocytic Leukemia (CLL) trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
Enrollment underperformance.
Phase II Adrenocortical Carcinoma trial by Dartmouth-Hitchcock Medical Center. Stop reason: OPERATIONAL.
unable to enroll subjects into the study